Although recent vaccine approvals have raised hopes of a turnaround in the pandemic later this year, renewed waves and new variants of the virus pose concerns for the outlook. Amid exceptional ...

Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie is currently conducting a pivotal Phase 3 clinical study titled ‘A ...